Luciferase activity was detected from cell lysates and was quantified by a Sirius luminometer (Berthold Detection Systems, Oak Ridge, TN) using a Luciferase assay system kit (Promega, Madison, WI). Treatment Groups: Seven different treatment groups were tested in a critically sized femoral defect in Lewis rats at age 3-4 months. There were 10 rats in each group with 5x10 6 RBMCs being implanted per femoral defect (Table 1) . 6 RBMCs transduced with one of the above listed vectors were impregnated onto a compression resistant collagen matrix (Medtronic, Memphis, TN) which was implanted into a unilateral, 7mm femoral defect in Lewis rats. In vivo imaging of the rats was performed weekly with a CCCD camera for 12 weeks to assay for in vivo luciferase expression. At 4wks and 8wks radiographs (Fig 1) were obtained to evaluate for bone formation. At 8wks the femurs were harvested and underwent biomechanical testing with a torque device, micro CT analysis (Fig 1) , and histologic analysis. RESULTS Healing rates were assessed at the 8wk time point using plain radiographic evaluation by three blinded, independent observers and manual palpation: Group I-7/10, Group II-7/10, Group IV-10/10, Group V-8/10, and in each of Groups III, VI, VII, 0/10. In vivo expression of luciferase was detected as early as 3 days in each group (Fig 2) . However, expression of Ad-Luc was not visualized at 2wks, whereas stable in vivo expression of LV-Luc occurred for 12wks after surgery (Fig 2) . Femurs that were healed using LV-BMP2 out-performed those that were healed using Ad-BMP2 during biomechanical tests ( Table 2) . DISCUSSION LV-BMP2 induces long term expression of BMP2 at the site of bone defects. We have demonstrated that prolonged gene expression is associated with higher healing rates, stiffness, and higher quality of bone repair in the rat femoral defect model. Furthermore, to our knowledge, this is the first demonstration of quantitatively tracked in vivo protein expression in a rat model. Although lentiviral gene therapy is not ready for clinical use, the prolonged gene expression compared to adenoviral gene therapy provides us with an opportunity to study the effect of duration of protein production on bone production and repair.
Fig. 2. Luciferase activity in vivo

